Xiangyu Zhao

Xiangyu Zhao

Auto-generated profile, based on publicly available information

Xiangyu Zhao

Center for Biophotonics, Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2012 in Applied Biochemistry and Microbiology
Verified
Journal Article
Closed access
PDF file
WLWenting Li
Wenting Li
XZX. Zhao
X. Zhao
SZS. Zou
S. Zou
YMYan Ma
Yan Ma
KZK. Zhang
K. Zhang
MZM. Zhang
M. Zhang
β-galactosidase, encoded by the lacZ gene in E. coli, can cleave lactose and structurally related compounds to galactose and glucose or structurally related products. Its activity can be measured using an artificial substrate, o-nitrophenyl-β-D-galactopyranoside (ONPG). Miller firstly described the standard quantitative assay of β-galactosidase activity in the cells of bacterial cultures by disrupting the cell membrane with the permeabilization solution instead of preparing cell extracts. Therefore, β-galactosidase became one of the most widely used reporters of gene expression in molecular biology to reflect intracellular gene expression difference. But the Miller assay procedure could not monitor the β-galactosidase reaction in real time and its results were greatly influenced by some operations in the Miller procedure, such as permeabilization time, reaction time and concentration of the cell suspension. A scanning method based on the Miller method to determine the intracellular β-galactosidase activity in E. coli Tuner (DE3) expressing β-galactosidase in real time was developed and the permeabilization time of cells was optimized for that. The comparison of 3 assays of β-galactosidase activity (Miller, colorimetric and scanning) was made. The results proved that scanning method for the determination of enzyme activity with using ONPG as substrate is simple, fast and reproducible.

28 June 2024 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
JSJingzhu Shao
Jingzhu Shao
XZXiangyu Zhao
Xiangyu Zhao
PTPing Tang
Ping Tang
BCBo Chen
Bo Chen
BXBorui Xu
Borui Xu
CWChongzhao Wu
Chongzhao Wu

28 May 2025 in The Analyst
Verified
Journal Article
Closed access
PDF file
YTYudong Tian
Yudong Tian
XZXiangyu Zhao
Xiangyu Zhao
JSJingzhu Shao
Jingzhu Shao
BXBingsen Xue
Bingsen Xue
LHLianting Huang
Lianting Huang
CWChongzhao Wu
Chongzhao Wu
An infrared spectral domain adversarial neural network (IRS-DANN) is proposed for clinical diagnosis of lung cancer.

26 February 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
XZXiangyu Zhao
Xiangyu Zhao
JSJingzhu Shao
Jingzhu Shao
YTYudong Tian
Yudong Tian
ZGZhiqiang Gui
Zhiqiang Gui
PTPing Tang
Ping Tang
CWChongzhao Wu
Chongzhao Wu

31 August 2026 in Advanced Optical Materials
Verified
Journal Article
Open access
PDF file
JSJingzhu Shao
Jingzhu Shao
PTPing Tang
Ping Tang
BXBorui Xu
Borui Xu
XZXiangyu Zhao
Xiangyu Zhao
YTYudong Tian
Yudong Tian
CWChongzhao Wu
Chongzhao Wu
Artificial intelligence has revolutionized optical device design, overcoming the efficiency bottlenecks of traditional methods. For holographic metasurfaces, conventional iterative algorithms suffer from time‐consuming iterations and convergence stagnation, especially as the complexity of 3D target fields increases. While deep learning‐based algorithms have improved the trade‐off between speed and image quality, most existing models remain constrained by predefined physical scenarios. To address these challenges, we develop LM‐PINN, a physics‐informed neural network that integrates local polynomial fitting with multi‐plane wave propagation, for the rapid design of terahertz 3D holographic metasurfaces. Through self‐supervised training, LM‐PINN enables direct end‐to‐end mapping from target holographic patterns to metasurface structures within a predefined holographic configuration, without labeled datasets. Both simulated and experimental results from LM‐PINN demonstrate higher imaging quality than traditional iterative algorithms. We further incorporate distance encoding into LM‐PINN, yielding Dist‐LM‐PINN. Dist‐LM‐PINN enables a single trained model to generalize across varying diffraction distances and demonstrate 2D/3D holographic scenarios without retraining by utilizing the precomputed electric‐field distributions at the metasurface plane as inputs. The proposed framework typically completes inference in less than 1 second, providing a multifold speed advantage over traditional algorithms and offering a fast and flexible framework for high‐quality, real‐time, and large‐scale 3D holographic technologies.

22 May 2026 in Biomedical Optics Express
Verified
Journal Article
Closed access
LHLianting Huang
Lianting Huang
XZXiangyu Zhao
Xiangyu Zhao
YTYudong Tian
Yudong Tian
JSJingzhu Shao
Jingzhu Shao
GLGang Liu
Gang Liu
CWChongzhao Wu
Chongzhao Wu
Lung cancer has high global morbidity and mortality, and accurate early diagnosis is critical for improving prognosis. Fine-needle aspiration (FNA) is a minimally invasive initial screening tool, but traditional analytical methods (e.g., hematoxylin and eosin staining) are subjective and prone to misdiagnosis. Fourier-transform infrared (FTIR) spectroscopy enables label-free analysis of biomolecular vibrations, and mass spectrometry detects metabolite changes. Here, FTIR and mass spectra were collected from FNA samples of lung cancer, with histopathology adopted as the diagnostic gold standard. A multimodal diagnostic network was developed, comprising modality-specific feature extraction branches and a hybrid fusion module, which integrates gated fusion and multi-head cross-attention mechanisms to capture correlations between FTIR and mass spectra. This architecture achieved an area under the curve (AUC) of 96.67% and a precision of 91.42%, outperforming single-modal approaches and conventional methods. Furthermore, model interpretability analysis was performed, which tentatively identified potential key biomarkers for lung cancer. This work seeks to provide a minimally invasive, rapid, and accurate tool for lung cancer diagnosis, thereby facilitating early clinical intervention and improving patient prognosis.